Skip to content

Immunocore

US · IMCR #2968 by market cap Listed 2021
26.41 -0.22 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:10

Recent news

  • Rating change
    Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/7
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $33
    Market Newswire · 2026/10/29
  • Rating change
    Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86
    Market Newswire · 2026/4/20
  • Rating change
    J.P. Morgan Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/8/21
  • Rating change
    TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/5/7
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $38
    Market Newswire · 2026/4/15
  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $73
    Market Newswire · 2026/5/7
  • H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $80
    Market Newswire · 2026/11/10
  • Rating change
    Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43
    Market Newswire · 2026/8/7
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $34
    Market Newswire · 2026/5/8
  • Rating change
    Immunocore Holdings (IMCR) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/6/4
  • Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $43
    Market Newswire · 2026/11/9
  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating
    Market Newswire · 2026/10/28
  • Rating change
    H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/11/5
  • Earnings Flash (IMCR) Immunocore Posts Q3 Loss $0.28 a Share, Vs. FactSet Est of $0.15 Loss
    MT Newswires · 2026/11/6
  • Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $42
    Market Newswire · 2026/11/13
  • Rating change
    Wells Fargo Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/4/14
  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $74
    Market Newswire · 2026/8/7
  • Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Announces Target Price $79
    Market Newswire · 2026/11/12
  • Rating change
    Jefferies Initiates Immunocore(IMCR.US) With Hold Rating, Announces Target Price $33
    Market Newswire · 2026/3/16
  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $72
    Market Newswire · 2026/2/26
  • Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $43
    Market Newswire · 2026/10/22
  • Rating change
    Needham Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $75
    Market Newswire · 2026/2/26
  • H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/10/27
  • Rating change
    Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $40
    Market Newswire · 2026/2/26

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.

Immunocore discussion 0 comments

Add a comment